Sublingual AKBA Exerts Antidepressant Effects in the Aβ-Treated Mouse Model
The 3-O-acetyl-11-keto-β-boswellic acid (AKBA) is the most active compound of <i>Boswellia serrata</i> proposed for treating neurodegenerative disorders, including Alzheimer’s disease (AD), characterized in its early phase by alteration in mood. Accordingly, we have previously demonstrat...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/11/5/686 |